Phase 1 8 trials
Phase 1
NCT07628881 Jun → Sep 2026 expected —
BeOne Medicines
Recruiting
No outcome recorded
Phase 1
NCT07548255 Apr 2026 → Mar 2029 expected mantle cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1
NCT07141511 Sep 2025 → Feb 2026 —
BeOne Medicines
Completed
No outcome recorded
Phase 1
NCT06859008 Aug 2025 → Jan 2029 expected MALT lymphoma , chronic lymphocytic leukemia/small lymphocytic lymphoma , diffuse large B-cell lymphoma , mantle cell lymphoma +2 City of Hope Medical Center
Recruiting
No outcome recorded
Phase 1
NCT06543043 Aug → Oct 2024 —
BeiGene
Completed
No outcome recorded
Phase 1
NCT05844111 May → Jun 2023 —
BeiGene
Completed
No outcome recorded
Phase 1
NCT04883957 Jul 2021 → Aug 2026 overdue neoplasm of mature B-cells BeiGene
Active not recruiting
No outcome recorded
Phase 1
NCT04277637 Mar 2020 → May 2027 expected neoplasm of mature B-cells BeOne Medicines
Active not recruiting
No outcome recorded
Phase 1/2 7 trials
Phase 1/2
NCT07687004 Aug 2026 → Aug 2027 expected plasma cell myeloma Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07638787 Jun 2026 → Sep 2027 expected large B-cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06697184 Jan 2025 → Nov 2029 expected B-cell chronic lymphocytic leukemia , mantle cell lymphoma BeOne Medicines
Recruiting
No outcome recorded
Phase 1/2
NCT06634589 Nov 2024 → Dec 2028 expected B-cell neoplasm BeOne Medicines
Recruiting
No outcome recorded
Phase 1/2
NCT05471843 Sep 2022 → Jul 2025 overdue mantle cell lymphoma BeiGene
Active not recruiting
No outcome recorded
Phase 1/2
NCT04973605 Sep 2021 → Nov 2026 expected refractory plasma cell neoplasm BeOne Medicines
Recruiting
No outcome recorded
Phase 1/2
NCT04771130 May 2021 → Feb 2028 expected acute myeloid leukemia , myelodysplastic syndrome , myelodysplastic/myeloproliferative neoplasm BeOne Medicines
Recruiting
No outcome recorded
Phase 2 19 trials
Phase 2
NCT07674810 Dec 2026 → Apr 2027 expected B-cell chronic lymphocytic leukemia M.D. Anderson Cancer Center
Not yet recruiting
No outcome recorded
Phase 2
NCT07508995 Sep 2026 → Jul 2031 expected B-cell chronic lymphocytic leukemia M.D. Anderson Cancer Center
Not yet recruiting
No outcome recorded
Phase 2
NCT07341191 Jun 2026 → Dec 2029 expected mantle cell lymphoma Canadian Cancer Trials Group
Recruiting
No outcome recorded
Phase 2
NCT07682415 Jun 2026 → Dec 2029 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Yi Shuhua
Not yet recruiting
No outcome recorded
Phase 2
NCT07671378 Jun 2026 → Dec 2027 expected B-cell chronic lymphocytic leukemia The First Affiliated Hospital with Nanjing Medical University
Recruiting
No outcome recorded
Phase 2
NCT07548710 May 2026 → May 2027 expected acute myeloid leukemia Ruijin Hospital
Recruiting
No outcome recorded
Phase 2
NCT07573670 May 2026 → Dec 2027 expected mixed phenotype acute leukemia The First Affiliated Hospital of Soochow University
Not yet recruiting
No outcome recorded
Phase 2
NCT07335887 Jan 2026 → Feb 2028 expected AL amyloidosis Peking University People's Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06547866 Dec 2025 → Dec 2028 expected Waldenstrom macroglobulinemia French Innovative Leukemia Organisation
Not yet recruiting
No outcome recorded
Phase 2
NCT06839053 Jun 2025 → Aug 2028 expected chronic lymphocytic leukemia/small lymphocytic lymphoma , mantle cell lymphoma Fred Hutchinson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT06849713 May 2025 → Mar 2028 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Massachusetts General Hospital
Recruiting
No outcome recorded
Phase 2
NCT06854003 Apr 2025 → Nov 2029 expected mantle cell lymphoma Christine Ryan
Recruiting
No outcome recorded
Phase 2
NCT06637501 Nov 2024 → Nov 2026 expected B-cell chronic lymphocytic leukemia BeOne Medicines
Active not recruiting
No outcome recorded
Phase 2
NCT06497062 Oct 2024 → Oct 2027 expected acute myeloid leukemia Shanghai Jiao Tong University School of Medicine
Active not recruiting
No outcome recorded
Phase 2
NCT06463691 Aug 2024 → Dec 2028 expected —
Tianjin Medical University Cancer Institute and Hospital
Recruiting
No outcome recorded
Phase 2
NCT06367374 May 2024 → Feb 2030 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 2
NCT05952037 Oct 2023 → Sep 2026 expected Waldenstrom macroglobulinemia BeOne Medicines
Active not recruiting
No outcome recorded
Phase 2
NCT05479994 Oct 2022 → Jan 2025 overdue chronic lymphocytic leukemia/small lymphocytic lymphoma BeiGene
Active not recruiting
No outcome recorded
Phase 2
NCT04271956 Feb 2020 → Aug 2026 overdue Richter transformation German CLL Study Group
Recruiting
No outcome recorded
Show 9 more trials Phase 3 5 trials
Phase 3
NCT07321652 Apr 2026 → Sep 2028 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Alliance for Clinical Trials in Oncology
Recruiting
No outcome recorded
Phase 3
NCT07277231 Jan 2026 → Feb 2031 expected chronic lymphocytic leukemia/small lymphocytic lymphoma BeOne Medicines
Recruiting
No outcome recorded
Phase 3
NCT06943872 Jun 2025 → Sep 2029 expected chronic lymphocytic leukemia/small lymphocytic lymphoma BeOne Medicines
Recruiting
No outcome recorded
Phase 3
NCT06742996 Mar 2025 → Aug 2028 expected mantle cell lymphoma BeOne Medicines
Recruiting
No outcome recorded
Phase 3
NCT06073821 Nov 2023 → Feb 2032 expected chronic lymphocytic leukemia/small lymphocytic lymphoma BeOne Medicines
Active not recruiting
No outcome recorded